InvestorsHub Logo
Followers 21
Posts 1321
Boards Moderated 0
Alias Born 06/28/2020

Re: medicinecat post# 36439

Thursday, 01/11/2024 11:28:28 AM

Thursday, January 11, 2024 11:28:28 AM

Post# of 36559
Have no idea lol,. but some bought recently at .05, they need Funding and some good data eventually I think, but can that happen with mf? is bmt right I really don't know ...I was going to buy some more but decided to buy rakr for a merger play possible ,05 to .10 jan22 1000% to 2000% gain maybe, see what happens lol. im still waiting to buy back in more soon here maybe..
https://ceo.ca/rvv

Filed 2024-01-05 09:50
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+400,000 vol 1,650,000
Filed 2024-01-04 13:48
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options $20,000
+400,000 vol
$0.05 each 1,650,000
Filed 2024-01-04 13:41
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Jackson, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options $20,000
+400,000 vol
$0.05 each 1,400,000
Filed 2024-01-04 13:37
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options $100,000
+2,000,000 vol
$0.05 each 16,500,000
Filed 2024-01-04 13:36
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options $100,000
+2,000,000 vol
$0.05 each
Filed 2024-01-04 13:35
Tx date 2022-11-29 $RVV
Revive Therapeutics Ltd. Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options $-32,500
-100,000 vol
$0.325 each 14,500,000
Filed 2024-01-04 13:34
Tx date 2022-11-01 $RVV
Revive Therapeutics Ltd. Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options $-50,000
-250,000 vol
$0.20 each 14,600,000
Filed 2024-01-04 13:31
Tx date 2024-01-02 $RVV
Revive Therapeutics Ltd. Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options $100,000
+2,000,000 vol
$0.05 each